CAS: 865305-30-2 - 5-[5-Iodo-4-methoxy-2-(1-methylethyl)phenoxy]-2,4-pyrimidinediamine
Formula:C14H17IN4O2
InChI:InChI=1S/C14H17IN4O2/c1-7(2)8-4-11(20-3)9(15)5-10(8)21-12-6-18-14(17)19-13(12)16/h4-7H,1-3H3,(H4,16,17,18,19)
InChI key:InChIKey=AATPYXMXFBBKFO-UHFFFAOYSA-N
SMILES:IC=1C=C(OC2=CN=C(N=C2N)N)C(=CC1OC)C(C)C
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2,4-Pyrimidinediamine, 5-[5-iodo-4-methoxy-2-(1-methylethyl)phenoxy]- REF: IN-DA0036CFCAS: 865305-30-2 | % | 178.00 €~579.00 € | Fri 29 Nov 24 | |
AF-353 REF: TM-T2087CAS: 865305-30-2 | 92.98% - 98.81% | 36.00 €~1,053.00 € | Thu 05 Dec 24 | |
AF 353 REF: 3D-BA165790CAS: 865305-30-2 | Min. 95% | To inquire | Thu 09 Jan 25 |
2,4-Pyrimidinediamine, 5-[5-iodo-4-methoxy-2-(1-methylethyl)phenoxy]-
CAS:865305-30-2
Formula:
C14H17IN4O2
Purity:
%
Color and Shape:
Solid
Molecular weight:
400.2149
Ref: IN-DA0036CF
25mg | 178.00 € | ||
50mg | 215.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
AF-353
CAS:865305-30-2
AF-353 (Ro-4), an effective and orally bioavailable antagonist of the P2X3/P2X2/3 receptor, inhibits human and …
Formula:
C14H17IN4O2
Purity:
92.98% - 98.81%
Color and Shape:
Solid
Molecular weight:
400.21
Ref: TM-T2087
1mg | 36.00 € | ||
2mg | 52.00 € | ||
5mg | 76.00 € | ||
10mg | 123.00 € | ||
25mg | 240.00 € | ||
50mg | 334.00 € | ||
100mg | 497.00 € | ||
200mg | 408.00 € | ||
500mg | 1,053.00 € | ||
1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
AF 353
CAS:865305-30-2
Antagonist of P2X3/P2X2/3 purinoreceptors
Formula:
C14H17IN4O2
Purity:
Min. 95%
Molecular weight:
400.22 g/mol
Ref: 3D-BA165790
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025